• Overview
  • Eligibility
  • More info
  • Locations

Prospective Observational Study of the Changes of Blood Flow of Arterial Anastomosis-site of Free Flap in Diabetic Patients Who Undergoing Free Flap Transfer (NCT03027219)

We aim to evaluate the flow change of arterial anastomosis site during free flap surgery in diabetic patients.
  • Drug: Alprostadil
    Vasodilator for anastomosis-site of free flap
    • Eglandin
Ages eligible for Study
18 Years to 79 Years
Genders eligible for Study
All
Accepts Healthy Volunteers
No
Inclusion Criteria:
  • Plan to receive free flap transfer under general anesthesia
  • Age: >=18 and <80 years old
  • History of diabetes mellitus
  • Administration of alprostadil during surgery
  • Volunteer, who are provided written informed consent prior to study participation
Exclusion Criteria:
  • Refuse the participation of study
  • >= American society of anesthesiologist physical status IV
  • Use of any vasopressor or inotropic for hemodynamic instability before participation of study
  • Inappropriate subjects who are identified by researchers
Objective: flow change of arterial anastomosis site during free flap surgery in diabetic patients.

Background: No research was published about flow change of arterial anastomosis site of the free flap during surgery.

Plan: Using Duplex sonography, various parameters related flap perfusion will be evaluated before and after the administration of alprostadil.

1 locations

Korea, Republic of (1)
  • Asan Medical Center
    recruiting
    Seoul, Korea, Republic of, 05505
Status:
recruiting
Type:
Observational
Phase:
-
Start:
30 January, 2017
Updated:
09 July, 2017
Participants:
44
Apply
A girl giving information about available additional trials.

FindMeCure helps you find, understand and join clinical trials from all over the world.

There are more clinical trials for your condition!